| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-12 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.31 | 7e-10 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.27 | 3e-05 |